Skip to main content

Dr. Albert D. Min, MD

Hepatology (Hepatology Physician)

  • Medicare participating

At a glance

Years since graduation
41
In the NPI registry since
2005
Medicare patients seen, 2024
313

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1985Medical school: University of Rochester School of Medicine and Dentistry
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hepatology Physician primary
    NY license 170352
  • Gastroenterology Physician
    NY license 170352

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hepatology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
313
Services billed
782
Patients’ average age
72
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes376210
Measurement of liver stiffness204182
Established patient office or other outpatient visit, 30-39 minutes6967
New patient office or other outpatient visit, 45-59 minutes4141
New patient office or other outpatient visit, 60-74 minutes2323

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 4 companies reported 86 payments worth $59,086 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$47,556
Travel and Lodging$4,586
Consulting Fee$4,258
Food and Beverage$2,687

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jul 18, 2025Madrigal Pharmaceuticals
Jul 18, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$5,288
Aug 19, 2025Madrigal Pharmaceuticals
Aug 19, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Nov 18, 2025Madrigal Pharmaceuticals
Nov 18, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Dec 16, 2025Madrigal Pharmaceuticals
Dec 16, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Feb 20, 2025Madrigal Pharmaceuticals
Feb 20, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
May 15, 2025Madrigal Pharmaceuticals
May 15, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Jun 12, 2025Madrigal Pharmaceuticals
Jun 12, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Jan 30, 2025Gilead Sciences, Inc.
Jan 30, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;4112388;AHM;10065918
$3,790
Apr 25, 2025Gilead Sciences, Inc.
Apr 25, 2025
Compensation for services other than consulting (speaking, faculty)
Vemlidy · HBV
Company’s description;4128272;AHM;10065918
$3,790
Aug 19, 2025Gilead Sciences, Inc.
Aug 19, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;4180624;AHM;10065918
$3,790
All 31 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 16, 2025Madrigal Pharmaceuticals
Dec 16, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Dec 16, 2025Madrigal Pharmaceuticals
Dec 16, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to FLUSHING, NY
$239
Dec 15, 2025Madrigal Pharmaceuticals
Dec 15, 2025
Consulting Fee$1,058
Nov 24, 2025GlaxoSmithKline, LLC.
Nov 24, 2025
Consulting Fee$3,200
Nov 18, 2025Madrigal Pharmaceuticals
Nov 18, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Nov 18, 2025Madrigal Pharmaceuticals
Nov 18, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to QUEENS, NY
$254
Oct 24, 2025Gilead Sciences, Inc.
Oct 24, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;4249460;GTF;10065918
$600
Oct 10, 2025Gilead Sciences, Inc.
Oct 10, 2025
Compensation for services other than consulting (speaking, faculty)
Vemlidy · HBV
Company’s description;4265375;AHM;10065918
$3,790
Oct 10, 2025Gilead Sciences, Inc.
Oct 10, 2025
Travel and Lodging
Vemlidy · HBV · travel to New York, NY · in-kind
Company’s description;4327621;AHM;10065918
$508
Aug 19, 2025Madrigal Pharmaceuticals
Aug 19, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Aug 19, 2025Gilead Sciences, Inc.
Aug 19, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;4180624;AHM;10065918
$3,790
Aug 14, 2025Gilead Sciences, Inc.
Aug 14, 2025
Travel and Lodging
Epclusa · HCV · travel to New York, NY · in-kind
Company’s description;4327856;AHM;10065918
$486
Jul 18, 2025Madrigal Pharmaceuticals
Jul 18, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$5,288
Jul 18, 2025Madrigal Pharmaceuticals
Jul 18, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind
$305
Jul 18, 2025Madrigal Pharmaceuticals
Jul 18, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind
$244
Jul 18, 2025Madrigal Pharmaceuticals
Jul 18, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind
$103
Jun 12, 2025Madrigal Pharmaceuticals
Jun 12, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Jun 12, 2025Madrigal Pharmaceuticals
Jun 12, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to FLUSHING, NY
$204
May 15, 2025Madrigal Pharmaceuticals
May 15, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
May 9, 2025Gilead Sciences, Inc.
May 9, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA
Company’s description;4027207;GTF;10065918
$107
May 9, 2025Gilead Sciences, Inc.
May 9, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA
Company’s description;4027063;GTF;10065918
$65.00
Apr 25, 2025Gilead Sciences, Inc.
Apr 25, 2025
Compensation for services other than consulting (speaking, faculty)
Vemlidy · HBV
Company’s description;4128272;AHM;10065918
$3,790
Apr 25, 2025Gilead Sciences, Inc.
Apr 25, 2025
Travel and Lodging
Vemlidy · HBV · travel to New York, NY · in-kind
Company’s description;4327830;AHM;10065918
$441
Mar 13, 2025Gilead Sciences, Inc.
Mar 13, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;3978785;GTF;10065918
$3,240
Mar 1, 2025Gilead Sciences, Inc.
Mar 1, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA · in-kind
Company’s description;4026749;GTF;10065918
$393
Mar 1, 2025Gilead Sciences, Inc.
Mar 1, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA · in-kind
Company’s description;4026744;GTF;10065918
$350
Mar 1, 2025Gilead Sciences, Inc.
Mar 1, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA · in-kind
Company’s description;4027115;GTF;10065918
$284
Feb 20, 2025Madrigal Pharmaceuticals
Feb 20, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,878
Feb 20, 2025Madrigal Pharmaceuticals
Feb 20, 2025
Travel and Lodging
REZDIFFRA · LIVER DISEASE · travel to NEW YORK, NY
$95.07
Jan 30, 2025Gilead Sciences, Inc.
Jan 30, 2025
Compensation for services other than consulting (speaking, faculty)
Epclusa · HCV
Company’s description;4112388;AHM;10065918
$3,790
Jan 24, 2025Gilead Sciences, Inc.
Jan 24, 2025
Travel and Lodging
Epclusa · HCV · travel to New York, NY · in-kind
Company’s description;3956940;AHM;10065918
$508

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Other Hepatology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 1, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1396720256. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.